期刊文献+

碘海醇所致造影剂肾病的危险因素分析 被引量:17

Risk factors of nephropathy induced by contrast agent iohexol
下载PDF
导出
摘要 目的分析碘海醇所致造影剂肾病(CIN)的危险因素。方法收集在河北医科大学第一医院心内科行经皮冠状动脉造影的646例患者临床资料,根据造影剂肾病的诊断标准分为CIN组(n=116)和非CIN组(n=530),比较两组患者基础疾病、自身情况的差异,采用Logistic回归分析危险因素。结果 CIN组患者和非CIN组患者的2型糖尿病、慢性肾脏病、心力衰竭、低血压、心肌梗死、急诊PCI例数以及年龄、造影剂用量差异有统计学意义(P<0.05)。Logistic回归分析显示:2型糖尿病、慢性肾脏病、心力衰竭、低血压、心肌梗死、年龄≥70岁、造影剂用量≥200 ml、急诊PCI是发生造影剂肾病的危险因素。结论碘海醇所致造影剂肾病的发生受到基础疾病、自身情况、造影剂用量等因素的影响,对于存在CIN高危因素的患者应引起临床上的高度重视。 【Objective】To analyze the risk factors of nephropathy induced by contrast agent iohexol.【Methods】Totally 646 patients who received percutaneous coronary angiography in the Department of Cardiology in our hospital were enrolled and divided into contrast induced nephropathy(CIN) group(n = 116) and non CIN group(n = 530) according to diagnostic criteria of contrast induced nephropathy. Differences in underlying diseases and patient’s own situation were compared between the two groups, and the risk factors were analyzed by Logistic regression analysis.【Results】There were differences in the incidences of type 2 diabetes, chronic kidney diseases, heart failure, hypotension, myocardial infarction, emergency PCI cases and age, contrast agent volume between both groups(P 〈0.05). Logistic regression analysis showed that type 2 diabetes, chronic kidney diseases, heart failure, hypotension,myocardial infarction, age older than 70 years, contrast agent volume ≥ 200 ml and emergency PCI were the risk factors of contrast induced nephropathy.【Conclusions】The occurrence of nephropathy induced by contrast agent iohexol is affected by underlying diseases, patient’s own situation and contrast agent volume. High attention should be paid to patients with high rick factors of contrast induced nephropathy.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第9期110-112,共3页 China Journal of Modern Medicine
基金 河北省卫生厅(No:ZD20140303)
关键词 经皮冠状动脉介入治疗 造影剂肾病 危险因素 碘海醇 percutaneous coronary artery interventional therapy contrast induced nephropathy(CIN) risk factor iohexol
  • 相关文献

参考文献10

二级参考文献41

  • 1Briguori C, Airoldi F, Morici N, et al. New Pharmacological protocols toprevent or reduce contrast media nephropathy [ J ]. Minerva Cardioangiol, 2005, 53(1):49-58.
  • 2Cavusoglu E, Chhabra S, Marmur J D, et al. The prevention of contrast-induced nephropathy in patients undergoing percuta- neous coronary intervention[ J ]. Minerva Cardioangiol, 2004, 52(5) :419-432.
  • 3Mc Cullough P A, Adam A, Becker C R, et al. Epidemiology and prognostic implications of contrast-induced nephropathy [J]. Am J Cardiol, 2006, 98(6A):5K-13K.
  • 4Rihal C S, Textor S C, Grill D E, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention [J]. Circulation, 2002, 105(19): 2259- 2264.
  • 5Asff A, Preston R A, Roth D. Radiocontrast-induced nephropathy[J]. Am J Ther, 2003, 10(2):137-147.
  • 6Bartholomew B A, Harjai K J, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification [ J]. Am J Cardiol, 2004, 93 (12) : 1515-1519.
  • 7Toprak O, Cirit M, Yesil M, et al. Impact of diabetic and prediabetic state on development of contrast-induced nephropathy in patients with chronic kodey disease[J]. Nephrol Dial Transplant, 2007, 22(3) : 819-826.
  • 8Cohen D, Buertde G, Perruchoud A P, et al. Hypertension is an independent risk factor for contrast nephropathy after pereutaneous coronary intervention [ J ]. Int J Cardiol, 2006, 110 (2) :237-241.
  • 9Cirit M, Toprak O, Yesil M, et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy[J]. Nephron Clin Pract, 2006, 104(1):20-27.
  • 10Rosenstock J L, Bruno R, Kim J K, et al. The effect of with- drawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy[J]. Inter Urol Nephrol, 2008, 40(3):749-756.

共引文献46

同被引文献181

引证文献17

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部